Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02290912
Other study ID # 5606
Secondary ID
Status Completed
Phase N/A
First received November 6, 2014
Last updated December 2, 2015
Start date April 2014
Est. completion date December 2014

Study information

Verified date December 2015
Source Utah State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This is a randomized controlled trial to develop and test the efficacy of a multi-domain lifestyle behavioral intervention designed to promote healthier lifestyle behaviors linked to lower Alzheimer's disease risk among persons aged 40 to 64 years.


Description:

This is a randomized controlled trial to develop and test the efficacy of a multi-domain lifestyle behavioral intervention designed to promote healthier lifestyle behaviors linked to lower Alzheimer's disease risk among persons aged 40 to 64 years. Participants are randomized to treatment or control condition. The intervention, spanning a six month period, is an evidence-based health education program.


Recruitment information / eligibility

Status Completed
Enrollment 146
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 64 Years
Eligibility Inclusion Criteria:

- Age

- Residing or working in Cache County Utah

- Possessing smart phone or tablet

Exclusion Criteria:

- Dementia

- Pregnancy

- Untreated chronic major depression or other psychiatric condition

- Body mass index > 41

- Heart or stroke in prior 6 weeks

- Active cancer treatment

- Unwillingness to seek medical help when serious condition identified at intake

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Health education program
The intervention is a health education program including: informational website, experiential classes, custom smart phone or smart table application, wearable activity monitor, and informal coaching by student researchers to provide moral support for lifestyle behavioral change goals. Participants are not placed on any specific behavioral regimen but instead are encouraged to adopt healthier lifestyle behaviors per the evidence-based health education program, and to attend the experiential classes "cafeteria style" (i.e. based on their individual preferences).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Utah State University

Outcome

Type Measure Description Time frame Safety issue
Primary Picture Vocabulary Picture Vocabulary cognitive test score up to 7 months No
Primary Flanker Inhibitory Control and Attention Test Flanker Inhibitory Control and Attention Test cognitive test score up to 7 months No
Primary List Sorting Working Memory Test List Sorting Working Memory Test cognitive test score up to 7 months No
Primary Oral Symbol Digit Test Oral Symbol Digit Test cognitive test score up to 7 months No
Primary Montreal Cognitive Assessment Montreal Cognitive Assessment test score up to 7 months No
Primary Rey Auditory Verbal Learning Test Rey Auditory Verbal Learning Test score up to 7 months No
Primary Controlled Oral Word Association Test Controlled Oral Word Association Test score up to 7 months No
Primary Blood pressure Systolic and diastolic blood pressure up to 7 months No
Primary Body mass index Height and weight measurement for computing body mass index up to 7 months No
Primary Insulin insulin from venipuncture blood sample up to 7 months Yes
Primary Systemic inflammation C-reactive protein from venipuncture blood sample up to 7 months Yes
Primary Skin carotenoid status Biophotonic device that shines a light-emitting diode (LED) light at a site on the palm, to measure the skin carotenoid level in units of Raman counts up to 7 months No
Primary Triglycerides triglycerides from venipuncture blood sample up to 7 months Yes
Primary HDL Cholesterol High-density lipoprotein from venipuncture blood sample up to 7 months Yes
Primary LDL Cholesterol Low-density lipoprotein from venipuncture blood sample up to 7 months Yes
Primary Total cholesterol Total cholesterol from venipuncture blood sample up to 7 months Yes
Secondary Depression Center for Epidemiologic Studies - Depression scale score up to 7 months No
Secondary Motivation Situational Motivation Scale score up to 7 months No
Secondary Sleep Quality Pittsburgh Sleep Quality Index scale score up to 7 months No
Secondary Stress Perceived Stress Scale score up to 7 months No
Secondary Emotional Support Emotional Support subscale from the NIH Toolbox measures for social engagement up to 7 months No
Secondary Friendship Friendship subscale from the NIH Toolbox measures for social engagement up to 7 months No
Secondary Hostility Hostility subscale from the NIH Toolbox measures for social engagement up to 7 months No
Secondary Loneliness Loneliness subscale from the NIH Toolbox measures for social engagement up to 7 months No
Secondary Physical Activity - Moderate self-report question concerning # minutes per day doing moderate intensity physical activity (per Center for Disease Control definition) up to 7 months No
Secondary Physical Activity - Vigorous self-report question concerning # minutes per day doing vigorous intensity physical activity (per Center for Disease Control definition) up to 7 months No
Secondary Nutrition Diet History Questionnaire up to 7 months No
Secondary Readiness for Change Revised University of Rhode Island Change Assessment (R-URICA) readiness for change scale up to 7 months No
Secondary Metacognition Total score from a set of seven items (1=much worse to 5=much better), comparing current memory to how it was three years ago, adapted from a questionnaire of functional ability up to 7 months No
See also
  Status Clinical Trial Phase
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Withdrawn NCT03316898 - A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease Phase 1
Withdrawn NCT02860065 - CPC-201 Alzheimer's Disease Type Dementia: PET Study Phase 2
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Recruiting NCT05607615 - A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease Phase 2
Terminated NCT03307993 - Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease Phase 1
Recruiting NCT02912936 - A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease N/A
Active, not recruiting NCT02899091 - Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease Phase 1/Phase 2
Not yet recruiting NCT02868905 - Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women N/A
Completed NCT02907567 - Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease Phase 1/Phase 2
Completed NCT02516046 - 18F-AV-1451 Autopsy Study Phase 3
Terminated NCT02521558 - Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease N/A
Completed NCT02580305 - SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Phase 2
Recruiting NCT02247180 - Cognitive Rehabilitation in Alzheimer`s Disease N/A
Completed NCT02317523 - Alzheimer's Caregiver Coping: Mental and Physical Health N/A
Terminated NCT02220738 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors Phase 1
Completed NCT02260167 - Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol N/A
Completed NCT02256306 - The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study N/A
Completed NCT01922258 - Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Phase 3